During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...

For patients with moderately to severely active systemic lupus erythematosus (SLE), anifrolumab is associated with l ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

SELLAS Life Sciences Group (NASDAQ:SLS) announced on Thursday promising mid-stage trial results for SLS009, a highly ...

Immunotherapy is the form of treatment that redirects the immune system toward a pathogen or disease. In many cases, ...

Sellas Life Sciences (SLS) announced data from Phase 2a trial of SLS009 – tambiciclib -, a highly selective CDK9 inhibitor, in ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...

Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...